{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"description":"Response is Complete Response (CR) is Neutrophil count \\>/= 1.0 x 10\\^9/L, . Platelet count \\>/= 100 x 10\\^9/L, Bone marrow aspirate \\< 5% blasts, No extramedullary leukemia.","groups":[{"description":"See Detailed Description.\n\nClofarabine: Given IV\n\nCytarabine: Given IV\n\nDexamethasone: Given IV\n\nIdarubicin: Given IV\n\nRituximab: Given IV\n\nSorafenib: Given PO\n\nSorafenib Tosylate: Given PO\n\nVincristine: Given IV\n\nVincristine Sulfate: Given IV","id":"OG000","title":"Treatment (Combination Chemotherapy)"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Up to 2 months","title":"Participants Complete Response","type":"PRIMARY","unitOfMeasure":"Participants"}